Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online September 25, 2008
Stem Cells Vol. 26 No. 12 December 2008, pp. 3130 -3138
doi:10.1634/stemcells.2008-0777; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2008-0777v1
26/12/3130    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sedan, O.
Right arrow Articles by Binah, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sedan, O.
Right arrow Articles by Binah, O.

EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS

1,4,5-Inositol Trisphosphate-Operated Intracellular Ca2+ Stores and Angiotensin-II/Endothelin-1 Signaling Pathway Are Functional in Human Embryonic Stem Cell-Derived Cardiomyocytes

Oshra Sedana, Katya Dolnikova, Naama Zeevi-Levina,b, Noa Leibovicha, Michal Amita,b, Joseph Itskovitz-Eldora,b, Ofer Binaha

aRuth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel;
bRambam Medical Center, Haifa, Israel

Key Words. Human embryonic stem cell-derived cardiomyocytes • 1,4,5-Inositol trisphosphate • Angiotensin-II • Endothelin-1 • Intracellular Ca2+ transient • Contraction

Correspondence: Correspondence: Ofer Binah, Ph.D., Rappaport Institute, P.O. Box 9697, Haifa 31096, Israel. Telephone: 972-4-8295262; Fax: 972-4-8513919; e-mail: binah{at}tx.technion.ac.il; or Joseph Itskovitz-Eldor, M.D., Ph.D., Rambam Medical Center, Haifa 31096, Israel. Telephone: 972-4-8542536; e-mail: itskovitz{at}rambam.health.gov.il

Received on August 12, 2008; accepted for publication on September 11, 2008.

First published online in STEM CELLS EXPRESS  September 25, 2008.


On the basis of previous findings suggesting that in human embryonic stem cell-derived cardiomyocytes (hESC-CM) the sarcoplasmic reticulum Ca2+-induced release of calcium machinery is either absent or immature, in the present study we tested the hypothesis that hESC-CM contain fully functional 1,4,5-inositol trisphosphate (1,4,5-IP3)-operated intracellular Ca2+ ([Ca2+]i) stores that can be mobilized upon appropriate physiological stimuli. To test this hypothesis we investigated the effects of angiotensin-II (AT-II) and endothelin-1 (ET-1), which activate the 1,4,5-IP3 pathway, on [Ca2+]i transients and contractions in beating clusters of hESC-CM. Our major findings were that in paced hESC-CM both AT-II and ET-1 (10–9 to 10–7 M) increased the contraction amplitude and the maximal rates of contraction and relaxation. In addition, AT-II (10–9 to 10–7 M) increased the [Ca2+]i transient amplitude. The involvement of 1,4,5-IP3-dependent intracellular Ca2+ release in the inotropic effect of AT-II was supported by the findings that (a) hESC-CM express AT-II, ET-1, and 1,4,5-IP3 receptors determined by immunofluorescence staining, and (b) the effects of AT-II were blocked by 2 µM 2-aminoethoxyphenyl borate (a 1,4,5-IP3 receptor blocker) and U73122 [GenBank] (a phospholipase C blocker). In conclusion, these findings demonstrate for the first time that hESC-CM exhibit functional AT-II and ET-1 signaling pathways, as well as 1,4,5-IP3-operated releasable Ca2+ stores.

Disclosure of potential conflicts of interest is found at the end of this article.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.